ATI RN
Cardiovascular System Exam Questions Pdf
1. When administering an ACE inhibitor to a client with heart failure, what is the expected outcome of this medication?
- A. Decreased blood pressure
- B. Increased heart rate
- C. Increased cardiac output
- D. Decreased heart rate
Correct answer: C
Rationale: The correct answer is C: Increased cardiac output. ACE inhibitors are commonly used in heart failure to reduce the workload on the heart by decreasing blood pressure and increasing cardiac output. This ultimately helps improve the heart's efficiency and function. Choice A is incorrect because ACE inhibitors generally lead to a reduction in blood pressure. Choice B is incorrect as ACE inhibitors do not increase heart rate. Choice D is incorrect as ACE inhibitors do not typically decrease heart rate in the context of heart failure.
2. Which of the following is a central vasodilator and peripheral vasoconstrictor?
- A. Sympathetic nervous system
- B. Parasympathetic nervous system
- C. Norepinephrine
- D. Acetylcholine
Correct answer: A
Rationale: The correct answer is the Sympathetic nervous system. The sympathetic nervous system is a branch of the autonomic nervous system that is responsible for the fight-or-flight response. It causes vasodilation in central vessels to increase blood flow to vital organs during stress or exercise, while inducing vasoconstriction in peripheral vessels to redirect blood to essential areas. Norepinephrine and acetylcholine are neurotransmitters associated with the sympathetic and parasympathetic nervous systems, respectively, but they are not themselves central vasodilators and peripheral vasoconstrictors.
3. What is the narrowing of the arteries due to the buildup of plaque, which can lead to heart attacks and strokes?
- A. Coronary artery disease
- B. Peripheral artery disease
- C. Aortic stenosis
- D. Mitral valve prolapse
Correct answer: A
Rationale: Coronary artery disease is the correct answer. It is the narrowing or blockage of the coronary arteries due to plaque buildup, which can lead to heart attacks and other cardiovascular issues. Choice B, Peripheral artery disease, involves the narrowing of arteries in the limbs, not specifically the coronary arteries. Choice C, Aortic stenosis, refers to the narrowing of the aortic valve opening, not the arteries. Choice D, Mitral valve prolapse, is a condition where the valve between the left atrium and left ventricle doesn't close properly, unrelated to arterial narrowing.
4. The client on spironolactone (Aldactone) has a potassium level of 5.8 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer a potassium supplement.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: With a potassium level of 5.8 mEq/L, which is high, the priority action for the nurse is to hold the spironolactone. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, it is crucial to prevent exacerbating hyperkalemia by discontinuing the medication. Notifying the healthcare provider is necessary for further guidance and potential adjustments to the treatment plan. Administering a potassium supplement (Choice B) would be contraindicated since the client already has elevated potassium levels. Continuing the spironolactone as ordered (Choice C) can worsen hyperkalemia. Increasing the dose of spironolactone (Choice D) would be unsafe and exacerbate the high potassium levels.
5. What is a condition where the heart's electrical system malfunctions, leading to an irregular heartbeat or arrhythmia?
- A. Arrhythmia
- B. Bradycardia
- C. Tachycardia
- D. Ventricular fibrillation
Correct answer: A
Rationale: The correct answer is A, Arrhythmia. Arrhythmia refers to an irregular heartbeat caused by the malfunction of the heart's electrical system. Bradycardia (choice B) is a condition characterized by a slow heart rate, while Tachycardia (choice C) is a condition characterized by a fast heart rate. Ventricular fibrillation (choice D) is a life-threatening arrhythmia where the heart's lower chambers quiver erratically.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access